Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse
Abstract Background Migraine is a disabling neurologic disease that can fluctuate over time in severity, frequency, and acute medication use. Harris Poll Migraine Report Card was a US population-based survey to ascertain quantifiable distinctions amongst individuals with current versus previous high...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | The Journal of Headache and Pain |
Subjects: | |
Online Access: | https://doi.org/10.1186/s10194-024-01725-2 |
_version_ | 1797273855227592704 |
---|---|
author | Amaal J. Starling Roger Cady Dawn C. Buse Meghan Buzby Charlie Spinale Kathy Steinberg Kevin Lenaburg Steven Kymes |
author_facet | Amaal J. Starling Roger Cady Dawn C. Buse Meghan Buzby Charlie Spinale Kathy Steinberg Kevin Lenaburg Steven Kymes |
author_sort | Amaal J. Starling |
collection | DOAJ |
description | Abstract Background Migraine is a disabling neurologic disease that can fluctuate over time in severity, frequency, and acute medication use. Harris Poll Migraine Report Card was a US population-based survey to ascertain quantifiable distinctions amongst individuals with current versus previous high-frequency headache/migraine and acute medication overuse (HFM+AMO). The objective of this report is to compare self-reported experiences in the migraine journey of adults with HFM+AMO to those who previously experienced HFM+AMO but currently have a sustained reduction in headache/migraine frequency and acute medication use. Methods An online survey was available to a general population panel of adults (≥18 years) with migraine per the ID Migraine™ screener. Respondents were classified into “current HFM+AMO” (within the last few months had ≥8 headache days/month and ≥10 days/month of acute medication use; n=440) or “previous HFM+AMO” (previously had HFM+AMO, but within the last few months had ≤7 headache days/month and ≤9 days/month of acute medication use; n=110). Survey questions pertained to demographics, diagnosis, living with migraine, healthcare provider (HCP) communication, and treatment. Results Participants in the current HFM+AMO group had 15.2 monthly headache days and 17.4 days of monthly acute medication use in last few months compared to 4.2 and 4.1 days for the previous HFM+AMO group, respectively. Overall, current preventive pharmacologic treatment use was low (15-16%; P>0.1 for current vs previous) in both groups. Previous HFM+AMO respondents reported better current acute treatment optimization. More respondents with current (80%) than previous HFM+AMO (66%) expressed concern with their current health (P<0.05). More than one-third of both groups wished their HCP better understood their mental/emotional health (current 37%, previous 35%; P>0.1 for current vs previous) and 47% (current) to 54% (previous) of respondents worried about asking their HCP too many questions (P>0.1 for current vs previous). Conclusion Apart from optimization of acute medication, medical interventions did not significantly differentiate between the current and previous HFM+AMO groups. Use of preventive pharmacological medication was low in both groups. Adults with current HFM+AMO more often had health concerns, yet both groups expressed concerns of disease burden. Optimization of acute and preventive medication and addressing mental/emotional health concerns of patients are areas where migraine care may impact outcomes regardless of their disease burden. Graphical Abstract |
first_indexed | 2024-03-07T14:50:07Z |
format | Article |
id | doaj.art-f6d2ea6da8204c00ab109e81db1a5cfb |
institution | Directory Open Access Journal |
issn | 1129-2377 |
language | English |
last_indexed | 2024-03-07T14:50:07Z |
publishDate | 2024-02-01 |
publisher | BMC |
record_format | Article |
series | The Journal of Headache and Pain |
spelling | doaj.art-f6d2ea6da8204c00ab109e81db1a5cfb2024-03-05T19:47:58ZengBMCThe Journal of Headache and Pain1129-23772024-02-0125111410.1186/s10194-024-01725-2Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuseAmaal J. Starling0Roger Cady1Dawn C. Buse2Meghan Buzby3Charlie Spinale4Kathy Steinberg5Kevin Lenaburg6Steven Kymes7Mayo ClinicRK ConsultsAlbert Einstein College of MedicineCoalition for Headache and Migraine Patients (CHAMP)The Harris PollThe Harris PollClusterbusters, IncLundbeck LLCAbstract Background Migraine is a disabling neurologic disease that can fluctuate over time in severity, frequency, and acute medication use. Harris Poll Migraine Report Card was a US population-based survey to ascertain quantifiable distinctions amongst individuals with current versus previous high-frequency headache/migraine and acute medication overuse (HFM+AMO). The objective of this report is to compare self-reported experiences in the migraine journey of adults with HFM+AMO to those who previously experienced HFM+AMO but currently have a sustained reduction in headache/migraine frequency and acute medication use. Methods An online survey was available to a general population panel of adults (≥18 years) with migraine per the ID Migraine™ screener. Respondents were classified into “current HFM+AMO” (within the last few months had ≥8 headache days/month and ≥10 days/month of acute medication use; n=440) or “previous HFM+AMO” (previously had HFM+AMO, but within the last few months had ≤7 headache days/month and ≤9 days/month of acute medication use; n=110). Survey questions pertained to demographics, diagnosis, living with migraine, healthcare provider (HCP) communication, and treatment. Results Participants in the current HFM+AMO group had 15.2 monthly headache days and 17.4 days of monthly acute medication use in last few months compared to 4.2 and 4.1 days for the previous HFM+AMO group, respectively. Overall, current preventive pharmacologic treatment use was low (15-16%; P>0.1 for current vs previous) in both groups. Previous HFM+AMO respondents reported better current acute treatment optimization. More respondents with current (80%) than previous HFM+AMO (66%) expressed concern with their current health (P<0.05). More than one-third of both groups wished their HCP better understood their mental/emotional health (current 37%, previous 35%; P>0.1 for current vs previous) and 47% (current) to 54% (previous) of respondents worried about asking their HCP too many questions (P>0.1 for current vs previous). Conclusion Apart from optimization of acute medication, medical interventions did not significantly differentiate between the current and previous HFM+AMO groups. Use of preventive pharmacological medication was low in both groups. Adults with current HFM+AMO more often had health concerns, yet both groups expressed concerns of disease burden. Optimization of acute and preventive medication and addressing mental/emotional health concerns of patients are areas where migraine care may impact outcomes regardless of their disease burden. Graphical Abstracthttps://doi.org/10.1186/s10194-024-01725-2Acute medication overuseHigh-frequency migraineChronic migrainePatient perspectiveHarris PollSurvey |
spellingShingle | Amaal J. Starling Roger Cady Dawn C. Buse Meghan Buzby Charlie Spinale Kathy Steinberg Kevin Lenaburg Steven Kymes Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse The Journal of Headache and Pain Acute medication overuse High-frequency migraine Chronic migraine Patient perspective Harris Poll Survey |
title | Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse |
title_full | Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse |
title_fullStr | Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse |
title_full_unstemmed | Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse |
title_short | Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse |
title_sort | harris poll migraine report card population based examination of high frequency headache migraine and acute medication overuse |
topic | Acute medication overuse High-frequency migraine Chronic migraine Patient perspective Harris Poll Survey |
url | https://doi.org/10.1186/s10194-024-01725-2 |
work_keys_str_mv | AT amaaljstarling harrispollmigrainereportcardpopulationbasedexaminationofhighfrequencyheadachemigraineandacutemedicationoveruse AT rogercady harrispollmigrainereportcardpopulationbasedexaminationofhighfrequencyheadachemigraineandacutemedicationoveruse AT dawncbuse harrispollmigrainereportcardpopulationbasedexaminationofhighfrequencyheadachemigraineandacutemedicationoveruse AT meghanbuzby harrispollmigrainereportcardpopulationbasedexaminationofhighfrequencyheadachemigraineandacutemedicationoveruse AT charliespinale harrispollmigrainereportcardpopulationbasedexaminationofhighfrequencyheadachemigraineandacutemedicationoveruse AT kathysteinberg harrispollmigrainereportcardpopulationbasedexaminationofhighfrequencyheadachemigraineandacutemedicationoveruse AT kevinlenaburg harrispollmigrainereportcardpopulationbasedexaminationofhighfrequencyheadachemigraineandacutemedicationoveruse AT stevenkymes harrispollmigrainereportcardpopulationbasedexaminationofhighfrequencyheadachemigraineandacutemedicationoveruse |